Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 5
Submit an article Journal homepage
439
Views
10
CrossRef citations to date
0
Altmetric
Hematology

Healthcare resource utilization and costs among patients with steroid-resistant chronic graft-versus-host disease in the United States: a retrospective claims database analysis

Jingbo Yua Incyte Corporation, Wilmington, DE, USACorrespondence[email protected]
,
Lincy S. Lalb Optum, Inc., Eden Prairie, MN, USA
,
Amy Andersonb Optum, Inc., Eden Prairie, MN, USA
,
Mary DuCharmeb Optum, Inc., Eden Prairie, MN, USA
,
Shreekant Parasuramana Incyte Corporation, Wilmington, DE, USA
&
Daniel Weisdorfc Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Pages 755-759 | Received 02 Oct 2020, Accepted 18 Feb 2021, Published online: 10 Mar 2021

References

  • Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443–458.
  • D'Souza A, Fretham C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides; 2018 [cited 2019 October 8]. Available from: https://www.cibmtr.org.
  • Ratanatharathorn V, Ayash L, Lazarus HM, et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant. 2001;28(2):121–129.
  • Arai S, Arora M, Wang T, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015;21(2):266–274.
  • Wingard JR, Majhail NS, Brazauskas R, et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011;29(16):2230–2239.
  • Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017;129(1):30–37.
  • Garnett C, Apperley JF, Pavlů J. Treatment and management of graft-versus-host disease: improving response and survival. Ther Adv Hematol. 2013;4(6):366–378.
  • Flowers ME, Martin PJ. How we treat chronic graft-versus-host disease. Blood. 2015;125(4):606–615.
  • Flowers MED, Storer B, Carpenter P, et al. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14(12):1380–1384.
  • Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med. 2017;377(26):2565–2579.
  • Wolff D, Schleuning M, von Harsdorf S, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(1):1–17.
  • Yalniz FF, Murad MH, Lee SJ, et al. Steroid refractory chronic graft-versus-host disease: cost-effectiveness analysis. Biol Blood Marrow Transplant. 2018;24(9):1920–1927.
  • Razgallah Khrouf M, Achour L, Thabti A, et al. Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia. J Mark Access Health Policy. 2017;5(1):1335161.
  • Khera N, Emmert A, Storer BE, et al. Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens. Oncologist. 2014;19(6):639–644.
  • Khera N, Hamilton BK, Pidala JA, et al. Employment, insurance, and financial experiences of patients with chronic graft-versus-host disease in North America. Biol Blood Marrow Transplant. 2019;25(3):599–605.
  • US Bureau of Labor Statistics. Consumer price index. U.S. Medical Care. Series ID: CUUR0000SAM [cited 2019 December 12]. Available from: http://data.bls.gov/cgi-bin/surveymost?cu.
  • Saito AM, Cutler C, Zahrieh D, et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant. 2008;14(2):197–207.
  • Yu J, Lal L, Anderson A, et al. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation. Support Care Cancer. 2020;28(11):5491–5499.
  • Hamilton BK, Storer BE, Wood WA, et al. Disability related to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26(4):772–777.
  • Kilgour JM, Wali G, Gibbons E, et al. Systematic review of patient-reported outcome measures in graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26(5):e113–e127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.